Ticker Symbol: MXCT

MaxCyte Inc

$12.94 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001287098

Company Profile

MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization.

Sector: Professional, Scientific, and Technical Services

Industry: Research and Development in Biotechnology

Standard Industrial Classification Code (SIC code): 8731

Address: 22 Firstfield Rd Ste 110

Website: https://www.maxcyte.com/

CEO: Douglas Doerfler

Tags: N/A

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $3.00

Change: -$0.02 ( -0.66%)

Days Range: $2.96 - $3.05

Beta: -

52wk. High: -

52wk. Low: -

Ytd. Change -0.66%

50 Day Moving Average: -

200 Day Moving Average: -

Shares Outstanding: 103548943

Valuation

Market Cap: 31.1B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A